Holen Sie sich die Stockscreener-App
0.3082
0.06%
0.0002
Handel nachbörslich:
.32
0.0118
+3.83%
Schlusskurs vom Vortag:
$0.308
Offen:
$0.3102
24-Stunden-Volumen:
961.03K
Relative Volume:
0.29
Marktkapitalisierung:
$53.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.23M
KGV:
-0.4403
EPS:
-0.7
Netto-Cashflow:
$-11.54M
1W Leistung:
+9.88%
1M Leistung:
-9.72%
6M Leistung:
-61.33%
1J Leistung:
-76.11%
1-Tages-Spanne:
$0.3046
$0.3239
1-Wochen-Bereich:
$0.2842
$0.36
52-Wochen-Spanne:
$0.264
$2.10
Renovaro Inc Stock (RENB) Company Profile
Firmenname
Renovaro Inc
Sektor
Branche
Telefon
45 39179840
Adresse
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Vergleichen Sie RENB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.3082 | 63.31M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovaro Inc Aktie (RENB) Neueste Nachrichten
What analysts say about Renovaro Inc. stockConsistently profitable trades - Autocar Professional
Renovaro Inc. Stock Analysis and ForecastMassive stock growth - jammulinksnews.com
Is Renovaro Inc. a good long term investmentRapid wealth accumulation - jammulinksnews.com
What drives Renovaro Inc. stock priceExceptional growth trajectory - jammulinksnews.com
Can Renovaro Inc. stock recover from recent declineDaily Breakout Picks - Newser
What makes Renovaro Inc. stock price move sharplySmart Return Focused Trading - Newser
Renovaro Biosciences (RENB) Achieves Milestone with Innovative C - GuruFocus
Revolutionary Dendritic Cell Therapy Slashes Pancreatic Cancer Tumors by 81% in Groundbreaking Study - Stock Titan
Renovaro Inc (RENB) Stock: A Comprehensive 52-Week Review - investchronicle.com
How did Renovaro's expenses impact profits in Q2 2025? - AInvest
Renovaro Rockets 20% Higher on Legal Drama—Biotech's High-Stakes Merger Showdown - AInvest
Why Renovaro Inc. stock attracts strong analyst attentionFree Stock Market Expert Consultation - Newser
How Renovaro Inc. stock performs during market volatilityFree Consultation - Newser
Renovaro receives Nasdaq notice for missing annual shareholder meeting - Investing.com Australia
Renovaro receives Nasdaq notice for missing annual shareholder meeting By Investing.com - Investing.com Nigeria
Renovaro Biosciences Receives Nasdaq Compliance Notice - TipRanks
Renovaro BioSciences strengthens balance sheet through debt conversion - TipRanks
AI Healthcare Pioneer Renovaro Eliminates $9.7M Debt Through Strategic Conversion to Power Growth - Stock Titan
Renovaro Biosciences Restructures Debt with Exchange Agreement - TipRanks
Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives - The Globe and Mail
Predictive Oncology enters into $10M share purchase agreement with New Jersey-based firm - The Business Journals
Renovaro (NASDAQ:RENB) Shares Down 1.3% – Time to Sell? - Defense World
Renovaro Stock Soars 12.63% on Innovation, Partnerships - AInvest
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative - GuruFocus
Renovaro Inc (RENB Stock: A Sea of Opportunity - investchronicle.com
Ratios Uncovered: Breaking Down Renovaro Inc (RENB)’s Trailing Twelve Months Metrics - DWinneX
Renovaro Obtains a U.S. Patent for its AI-Powered Platform for Medication Discovery and Diagnostics - MSN
Smart Healthcare Is Taking Over. Here's Where the Money's Headed - Finansavisen
Renovaro Inc. shares fall 1.57% after-hours as AI healthcare adoption concerns rise. - AInvest
Renovaro Inc. (NASDAQ:RENB) Shares Bought by Nuveen Asset Management LLC - Defense World
Finanzdaten der Renovaro Inc-Aktie (RENB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):